SimplyGO being tested at 5500 ft by Lyn Cole

Posted on April 4th, 2012 by admin

Hope your jobs are as much fun as my “play” >

Having tested the new Respironics POC ‘Simply go’
[remember I live, at around 5500 ft altitude]…for hours while riding in a car as a passenger, to a Better breathers, to two funerals, … and a couple of times really slowly on the treadmill, (did I mention the cart is a dream come true),t oday I put it to a really long walk on the Treadmill,
I walked 2.6 miles, tested it for 95 minutes- moving up to faster pace, while switching around
using different pulse values and also with

3 different oxygen delivery systems…very interesting

The TTO ( Transtracheal oxygen system direct into my neck) consistently oxygenated close to 1% above other oxygen delivery systems.
The Oxyview glasses slightly lower than TTO, +/- 1%,
then with
the Salter (regular) cannula sats were trailing behind a full one to two percent lower than TTO…

you might say they work: >good-cannula >better-Oxyview >best -TTO.
I am so glad I have a TTO since that helps me use POC’s [or any system for that matter],more efficiently thus all will last longer for me.

as you can see, I test my oxygenation using two Nonin Onyx II oximeters (I have /use others- but they are always + or – one higher or lower (as is even the patient model Nonin Go2) so I stick with the professional model. Terry should like the shirt I wore for the second testing. (see blog below).

My walking speed the other test days was at 1 mph – boosted up to 1.5 and then 2 MPH today.
testing the Simply Go while using the pulse flow mode
beginning with the highest #6 ,and then trying it lower at # 5.5, 5, 4.5 pulse settings.

and finally the lowest *I* could go and have adequate sats, was on #4 pulse – at which time -when I tried going faster at 2 mph then the MX alarm sounded with the cannula and glasses… causing erratic oximeter readings up and down, fluctuating…
so I stopped, retried same thing with the TTO and then it didn’t MX out until after a full five minutes of walking… it kept me at 93-94% until the MX signal. the HR a nice 111.
While sitting it holds my O2 sats nicely around 93% even as low as #1.5 pulse.

Deduction – for ‘my’ slow walk needs, use #4.5 pulse when not ‘plugged in’- or – walk a little slower to save battery when out and about,
but of course with the tread mill and plugged into an outlet – I can use as high a pulse as desired.
For someone not having the 53% diffusion problem I have, this would be one heck of a sweet machine-
and at sea level it would probably be great for me too… as it is, it does work for me enough to be very helpful at times- and I am using it as a ‘back up’ of oxygen when I do my all day trips, it eliminates having to fill so many liquid portables.
Of course there is nothing like liquid oxygen if I want to walk 4 mph- then I require 16 liters.

It will be a while before I can chart all this … I post about my testing as I go along on several on-line support groups… folks are very interested…then I post on the blog leading up interest in the charts later… these blog pages have some pictures of the machine, and my testing – also the last one shows the COPD+ team on Feb 28th.

on my BLOG>
FEB 21 2012 SIMPLY GO POC introduced

http://www.wellsphere.com/copd-emphysema-article/feb-21-2012-simply-go-poc-introduced/1613430

Medicare/ Home medical equipment

Posted on March 20th, 2012 by admin

Video from the ALA 2012 Fight for Air Climb – Inspiration from Roxlyn Cole, Mike McBride, Others

Posted on March 3rd, 2012 by admin

Video from the ALA 2012 Fight for Air Climb – Inspiration from Roxlyn Cole, Mike McBride, Others.

COPD might be reversible?

Posted on December 21st, 2011 by admin

Bronchodilator reversibility in COPD.

Hanania NA, Celli BR, Donohue JF, Martin UJ

Section of Pulmonary and Critical Care Medicine, Asthma Clinical Research
Center (Dr Hanania), Baylor College of Medicine, Houston, TX; Division of
Pulmonary and Critical Care Medicine (Dr Celli), Brigham and Women¹s
Hospital, Harvard University, Boston, MA; Division of Pulmonary Disease
and Critical Care Medicine (Dr Donohue), University of North Carolina at
Chapel Hill, Chapel Hill, NC; and Clinical Research, Respiratory and
Inflammation Therapeutic Area (Dr Martin), AstraZeneca LP, Wilmington, DE.

Abstract

COPD is a preventable and treatable disease characterized by airflow
limitation that is not fully reversible. The diagnosis of COPD is based on
spirometric evidence of airways obstruction following bronchodilator
administration. Although it used to be commonly believed that patients
with COPD have largely irreversible airflow obstruction, evidence now
suggests that a considerable proportion of patients exhibit clinically
significant bronchodilator reversibility. The complexity and inherent
variability of a patient’s acute response to a bronchodilator and the lack
of a standardized procedure for assessing bronchodilator reversibility
have led to significant confusion surrounding this concept. Although
bronchodilator reversibility commonly is defined based on thresholds for
improvement in FEV(1), lung volume-based measures of pulmonary function
may be of particular importance in patients with severe COPD. The
usefulness of acute reversibility to short-acting bronchodilators in
predicting a patient’s long-term response to bronchodilator maintenance
therapy is also unclear, although most studies suggest that a lack of
acute response to short-acting bronchodilators does not preclude a
beneficial long-term response to maintenance bronchodilator treatment.
This review outlines recent findings about the prevalence and usefulness
of bronchodilator reversibility in patients with COPD based on the
available literature and proposes areas of future research.

PMID: 21972384

http://www.ncbi.nlm.nih.gov/pubmed/21972384

Understanding the Risks Associated With COPD and Anesthesia

Posted on November 10th, 2011 by admin

Are you a COPD patient who has undergone surgery? If so, after reading this article, you will have an opportunity to share about what precautions you took before you were administered general anesthesia.

The combination of COPD and anesthesia can be risky business. In fact, the long-term survival rate of COPD patients with severe airway disease who have any type of major surgery is poor. There is also a significant risk of postoperative complications, especially within the lungs. But does this mean that COPD patients should never have surgery?

Continue Reading

Our own Dr Adams

Posted on October 13th, 2011 by admin
Doctor Radio on Sirius satellite radio: Breathe easier on Tuesday mornings. Pulmonologist, Dr. Frank Adams will answer your questions about the lungs – and much more.

Harmonica Therapy

Posted on May 11th, 2011 by admin

Harmonica therapy is a very recent and exciting phenomenon, which has been in existence for less than eight years. There are at least a handful hospitals and health care establishments, mostly in the East and mid-East regions, where harmonicas are being used to treat or cure certain breathing problems, including chronic obstructive pulmonary disease (COPD), asthma, chronic bronchitis, emphysema,and other breathing-related conditions.

 

Read More

Pearl Therapeutics COPD drug passes test

Posted on April 7th, 2011 by admin

A mid-stage trial of Pearl Therapeutics Inc.’s combination therapy to treat chronic obstructive pulmonary disease is helping the company and COPD patients breathe easier.

Read more

Just Breathe: Body Has A Built-In Stress Reliever

Posted on April 7th, 2011 by admin

There are plenty of ways to relieve stress — exercise, a long soak in a hot bath, or even a massage. But believe it or not, something you’re doing right now, probably without even thinking about it, is a proven Continue reading →

Novaris Indacateral Beats Spiriva in COPD trial

Posted on April 7th, 2011 by admin

Novartis has been boosted by the release of late-stage data which suggests that its chronic obstructive pulmonary disease treatment Onbrez provided greater clinical benefit than Boehringer Ingelheim/Pfizer’s blockbuster Spiriva.

Results from the INTENSITY trial have been presented at the CHEST Continue reading →

 

Shop these great Respiratory products!

www.ERMAG.org